Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis

Julián E. Muñoz, Vinicius D. Luft, Juliana Amorim, Adriana Magalhães, Luciana Thomaz, Joshua D. Nosanchuk, Luiz R. Travassos, Carlos P. Taborda

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Paracoccidioidomycosis is a systemic granulomatous disease caused by Paracoccidioides spp. A peptide from the major diagnostic antigen gp43, named P10, induces a T-CD4<sup>+</sup> helper-1 immune response in mice and protects against intratracheal challenge with virulent P. brasiliensis. Previously, we evaluated the efficacy of the P10 peptide alone or combined with antifungal drugs in mice immunosuppressed and infected with virulent isolate of P. brasiliensis. In the present work, our data suggest that P10 immunization leads to an effective cellular immune response associated with an enhanced T cell proliferative response. P10-stimulated splenocytes increased nitric oxide (NO) production and induced high levels of IFN-γ, IL-1β and IL-12. Furthermore, significantly increased concentrations of pro-inflammatory cytokines were also observed in lung homogenates of immunized mice. P10 immunization was followed by minimal fibrosis in response to infection. Combined with antifungal drugs, P10 immunization most significantly improved survival of anergic infected mice. Administration of either itraconazole or sulfamethoxazole/trimethoprim together with P10 immunization resulted in 100 % survival up to 200 days post-infection, whereas untreated mice died within 80 days. Hence, our data show that P10 immunization promotes a strong specific immune response even in immunocompromised hosts and thus P10 treatment represents a powerful adjuvant therapy to chemotherapy.

Original languageEnglish (US)
Pages (from-to)177-188
Number of pages12
JournalMycopathologia
Volume178
Issue number3-4
DOIs
StatePublished - 2014

Fingerprint

Paracoccidioides
Paracoccidioides brasiliensis
Immunity
Immunization
immunization
immunity
Yeasts
peptides
yeasts
Peptides
mice
antifungal agents
immune response
Paracoccidioidomycosis
immunocompromised population
Itraconazole
sulfamethoxazole
itraconazole
trimethoprim
interleukin-12

Keywords

  • Anergy
  • Chemotherapy
  • P. brasiliensis
  • P10 immunization

ASJC Scopus subject areas

  • Plant Science
  • Agronomy and Crop Science
  • Applied Microbiology and Biotechnology
  • Microbiology
  • veterinary (miscalleneous)
  • Medicine(all)

Cite this

Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis. / Muñoz, Julián E.; Luft, Vinicius D.; Amorim, Juliana; Magalhães, Adriana; Thomaz, Luciana; Nosanchuk, Joshua D.; Travassos, Luiz R.; Taborda, Carlos P.

In: Mycopathologia, Vol. 178, No. 3-4, 2014, p. 177-188.

Research output: Contribution to journalArticle

Muñoz, Julián E. ; Luft, Vinicius D. ; Amorim, Juliana ; Magalhães, Adriana ; Thomaz, Luciana ; Nosanchuk, Joshua D. ; Travassos, Luiz R. ; Taborda, Carlos P. / Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis. In: Mycopathologia. 2014 ; Vol. 178, No. 3-4. pp. 177-188.
@article{fa90605926e34de19ef8802440e6ecf1,
title = "Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis",
abstract = "Paracoccidioidomycosis is a systemic granulomatous disease caused by Paracoccidioides spp. A peptide from the major diagnostic antigen gp43, named P10, induces a T-CD4+ helper-1 immune response in mice and protects against intratracheal challenge with virulent P. brasiliensis. Previously, we evaluated the efficacy of the P10 peptide alone or combined with antifungal drugs in mice immunosuppressed and infected with virulent isolate of P. brasiliensis. In the present work, our data suggest that P10 immunization leads to an effective cellular immune response associated with an enhanced T cell proliferative response. P10-stimulated splenocytes increased nitric oxide (NO) production and induced high levels of IFN-γ, IL-1β and IL-12. Furthermore, significantly increased concentrations of pro-inflammatory cytokines were also observed in lung homogenates of immunized mice. P10 immunization was followed by minimal fibrosis in response to infection. Combined with antifungal drugs, P10 immunization most significantly improved survival of anergic infected mice. Administration of either itraconazole or sulfamethoxazole/trimethoprim together with P10 immunization resulted in 100 {\%} survival up to 200 days post-infection, whereas untreated mice died within 80 days. Hence, our data show that P10 immunization promotes a strong specific immune response even in immunocompromised hosts and thus P10 treatment represents a powerful adjuvant therapy to chemotherapy.",
keywords = "Anergy, Chemotherapy, P. brasiliensis, P10 immunization",
author = "Mu{\~n}oz, {Juli{\'a}n E.} and Luft, {Vinicius D.} and Juliana Amorim and Adriana Magalh{\~a}es and Luciana Thomaz and Nosanchuk, {Joshua D.} and Travassos, {Luiz R.} and Taborda, {Carlos P.}",
year = "2014",
doi = "10.1007/s11046-014-9801-1",
language = "English (US)",
volume = "178",
pages = "177--188",
journal = "Mycopathologia",
issn = "0301-486X",
publisher = "Springer Netherlands",
number = "3-4",

}

TY - JOUR

T1 - Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis

AU - Muñoz, Julián E.

AU - Luft, Vinicius D.

AU - Amorim, Juliana

AU - Magalhães, Adriana

AU - Thomaz, Luciana

AU - Nosanchuk, Joshua D.

AU - Travassos, Luiz R.

AU - Taborda, Carlos P.

PY - 2014

Y1 - 2014

N2 - Paracoccidioidomycosis is a systemic granulomatous disease caused by Paracoccidioides spp. A peptide from the major diagnostic antigen gp43, named P10, induces a T-CD4+ helper-1 immune response in mice and protects against intratracheal challenge with virulent P. brasiliensis. Previously, we evaluated the efficacy of the P10 peptide alone or combined with antifungal drugs in mice immunosuppressed and infected with virulent isolate of P. brasiliensis. In the present work, our data suggest that P10 immunization leads to an effective cellular immune response associated with an enhanced T cell proliferative response. P10-stimulated splenocytes increased nitric oxide (NO) production and induced high levels of IFN-γ, IL-1β and IL-12. Furthermore, significantly increased concentrations of pro-inflammatory cytokines were also observed in lung homogenates of immunized mice. P10 immunization was followed by minimal fibrosis in response to infection. Combined with antifungal drugs, P10 immunization most significantly improved survival of anergic infected mice. Administration of either itraconazole or sulfamethoxazole/trimethoprim together with P10 immunization resulted in 100 % survival up to 200 days post-infection, whereas untreated mice died within 80 days. Hence, our data show that P10 immunization promotes a strong specific immune response even in immunocompromised hosts and thus P10 treatment represents a powerful adjuvant therapy to chemotherapy.

AB - Paracoccidioidomycosis is a systemic granulomatous disease caused by Paracoccidioides spp. A peptide from the major diagnostic antigen gp43, named P10, induces a T-CD4+ helper-1 immune response in mice and protects against intratracheal challenge with virulent P. brasiliensis. Previously, we evaluated the efficacy of the P10 peptide alone or combined with antifungal drugs in mice immunosuppressed and infected with virulent isolate of P. brasiliensis. In the present work, our data suggest that P10 immunization leads to an effective cellular immune response associated with an enhanced T cell proliferative response. P10-stimulated splenocytes increased nitric oxide (NO) production and induced high levels of IFN-γ, IL-1β and IL-12. Furthermore, significantly increased concentrations of pro-inflammatory cytokines were also observed in lung homogenates of immunized mice. P10 immunization was followed by minimal fibrosis in response to infection. Combined with antifungal drugs, P10 immunization most significantly improved survival of anergic infected mice. Administration of either itraconazole or sulfamethoxazole/trimethoprim together with P10 immunization resulted in 100 % survival up to 200 days post-infection, whereas untreated mice died within 80 days. Hence, our data show that P10 immunization promotes a strong specific immune response even in immunocompromised hosts and thus P10 treatment represents a powerful adjuvant therapy to chemotherapy.

KW - Anergy

KW - Chemotherapy

KW - P. brasiliensis

KW - P10 immunization

UR - http://www.scopus.com/inward/record.url?scp=84929510500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929510500&partnerID=8YFLogxK

U2 - 10.1007/s11046-014-9801-1

DO - 10.1007/s11046-014-9801-1

M3 - Article

C2 - 25135302

AN - SCOPUS:84929510500

VL - 178

SP - 177

EP - 188

JO - Mycopathologia

JF - Mycopathologia

SN - 0301-486X

IS - 3-4

ER -